EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA
Clinical trials for EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for High-Risk breast cancer: immunotherapy after standard care
Disease control Not yet recruitingThis phase 3 trial tests whether adding the immunotherapy drug pembrolizumab to standard post-surgery treatment can help prevent breast cancer from coming back in people with early-stage triple-negative breast cancer who still have cancer after initial chemo and immunotherapy. Ab…
Matched conditions: EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE3 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
Gut bacteria pill joins forces with chemo to fight aggressive breast cancer
Disease control Not yet recruitingThis study tests whether adding a live bacteria pill (MO-03) to standard chemotherapy and immunotherapy can improve outcomes for people with early-stage triple-negative breast cancer. About 50 participants will take the pill twice daily until surgery. The main goal is to see if t…
Matched conditions: EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Yuan Yuan • Aim: Disease control
Last updated May 22, 2026 14:01 UTC